Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Newly Diagnosed High Risk Acute Lymphoblastic Leukemia in Children

NCT02339350 is registered in ClinicalTrials.gov with The Korean Society of Pediatric Hematology Oncology as lead sponsor.

NCT NCT02339350
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02339350 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Newly Diagnosed High Risk Acute Lymphoblastic Leukemia in Children
Lead sponsor
The Korean Society of Pediatric Hematology Oncology
Phase
Phase 2
Overall status
Unknown status
Start date
January 31, 2015
Completion date
April 30, 2023
Enrollment
110 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia, child